MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-09-2026
Myomo DPO Ratio 2011-2026 | MYO
Annual DPO Ratio Myomo
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.8 | - | 44.5 | 46.5 | 25.3 | 179 | 214 | 191 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 214 | 25.3 | 105 |
Quarterly DPO Ratio Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.8 | 63.4 | 51.8 | - | 53.9 | 45.7 | 59.6 | - | 56.9 | 45.5 | 59.1 | - | 30.1 | 36.3 | 61.4 | - | 50.8 | 67.1 | 65.5 | - | 19.3 | 39.3 | 90.3 | - | 125 | 108 | 139 | - | 201 | 194 | 292 | - | 195 | 245 | 334 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 334 | 19.3 | 103 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Sensus Healthcare
SRTS
|
14.7 | $ 4.1 | -2.96 % | $ 66.9 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.86 | 3.25 % | $ 759 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.18 | -0.22 % | $ 329 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 335.31 | 2.37 % | $ 128 B | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.71 | 3.13 % | $ 33.3 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.91 | -0.32 % | $ 1.15 B | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 220.63 | 2.14 % | $ 15.5 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 23.46 | -3.32 % | $ 1.6 B | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.74 | 0.32 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.62 | -8.39 % | $ 33.7 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.37 | 2.22 % | $ 3.7 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Smith & Nephew plc
SNN
|
232 | $ 32.45 | - | $ 23.8 B |  Britain |
 |
LivaNova PLC
LIVN
|
68 | $ 64.75 | 2.28 % | $ 3.53 B | Britain |
 |
InspireMD
NSPR
|
72.3 | $ 1.74 | -0.57 % | $ 112 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.6 | 1.84 % | $ 1.57 B | USA |
 |
Penumbra
PEN
|
26.1 | $ 337.13 | 0.26 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 4.08 | -0.49 % | $ 603 M | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Viemed Healthcare
VMD
|
20.1 | $ 9.32 | -0.32 % | $ 363 M | USA |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Varex Imaging Corporation
VREX
|
42.5 | $ 10.72 | 0.28 % | $ 444 M | USA |
 |
Vivos Therapeutics
VVOS
|
98.4 | $ 1.24 | 7.37 % | $ 6.22 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 51.41 | - | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.29 | -1.15 % | $ 52.5 M | USA |
 |
Beyond Air
XAIR
|
133 | $ 0.74 | 0.01 % | $ 50.1 M | USA |
 |
Xtant Medical Holdings
XTNT
|
55.7 | $ 0.57 | 0.85 % | $ 76.2 M | USA |